These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 30189807)

  • 1. Non-Procrustean pathways for complex generic drugs development.
    Cristofoletti R; Schmidt S; Diniz A
    Ther Deliv; 2018 Sep; 9(9):605-607. PubMed ID: 30189807
    [No Abstract]   [Full Text] [Related]  

  • 2. Review of Complex Generic Drugs Delivered Through the Female Reproductive Tract: The Current Competitive Landscape and Emerging Role of Physiologically Based Pharmacokinetic Modeling to Support Development and Regulatory Decisions.
    Donnelly M; Tsakalozou E; Sharan S; Straubinger T; Bies R; Zhao L
    J Clin Pharmacol; 2020 Dec; 60 Suppl 2():S26-S33. PubMed ID: 33274513
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulatory Considerations of Bioequivalence Studies for Oral Solid Dosage Forms in Japan.
    Kuribayashi R; Takishita T; Mikami K
    J Pharm Sci; 2016 Aug; 105(8):2270-7. PubMed ID: 27372551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generic drug products in paediatrics: Where are the data?
    Illamola SM; Birnbaum AK; Sherwin CM
    Br J Clin Pharmacol; 2019 Sep; 85(9):1871-1873. PubMed ID: 31281980
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluating the bioequivalence of clopidogrel generic formulations.
    Tsoumani ME; Ntalas IV; Goudevenos JA; Tselepis AD
    Curr Med Res Opin; 2015 May; 31(5):861-4. PubMed ID: 25764150
    [No Abstract]   [Full Text] [Related]  

  • 6. Generics and cost-effective prescribing in Belgium: does bioequivalence always translate in therapeutic equivalence?
    Dupont AG; Heller F
    Acta Clin Belg; 2009; 64(5):406-14. PubMed ID: 19999388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative assessment of the switchability of generic products.
    Karalis V; Bialer M; Macheras P
    Eur J Pharm Sci; 2013 Nov; 50(3-4):476-83. PubMed ID: 23981332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioequivalence studies in Morocco.
    Zaoui S; Fadili W
    Pan Afr Med J; 2020; 36():279. PubMed ID: 33088408
    [No Abstract]   [Full Text] [Related]  

  • 9. Bioequivalence of generic drugs.
    Andrade C
    J Clin Psychiatry; 2015 Sep; 76(9):e1130-1. PubMed ID: 26455677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bioequivalence and generics of index drugs with narrow therapeutic margins].
    Le Corre P
    Presse Med; 2010 Feb; 39(2):169-76. PubMed ID: 19932591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Bioequivalence Approach for Generic Narrow Therapeutic Index Drugs: Evaluation of the Reference-Scaled Approach and Variability Comparison Criterion.
    Jiang W; Makhlouf F; Schuirmann DJ; Zhang X; Zheng N; Conner D; Yu LX; Lionberger R
    AAPS J; 2015 Jul; 17(4):891-901. PubMed ID: 25840883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effectiveness of generic agents in psychopharmacologic treatment.
    Kumet R; Gelenberg AJ
    Essent Psychopharmacol; 2005; 6(2):104-11. PubMed ID: 15765794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generics: need for clinical concern?
    Heller FR; Dupont AG
    Acta Clin Belg; 2009; 64(5):415-22. PubMed ID: 19999389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decision Science for Generic Drug Development and Review.
    Lionberger R
    J Clin Pharmacol; 2019 Sep; 59(9):1249-1251. PubMed ID: 31087559
    [No Abstract]   [Full Text] [Related]  

  • 15. Modeling and simulation of biopharmaceutical performance.
    Zhang X; Lionberger RA
    Clin Pharmacol Ther; 2014 May; 95(5):480-2. PubMed ID: 24747237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioequivalence, therapeutic equivalence and generic drugs.
    Verbeeck RK
    Acta Clin Belg; 2009; 64(5):379-83. PubMed ID: 19999384
    [No Abstract]   [Full Text] [Related]  

  • 17. Current regulatory approaches of bioequivalence testing.
    Karalis V; Macheras P
    Expert Opin Drug Metab Toxicol; 2012 Aug; 8(8):929-42. PubMed ID: 22681436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Assessment of equivalence of the original tamsulosin and its generics].
    Zyrianov SK; Belousov IuB; Kamaev AV; Krivoborodov GG
    Urologiia; 2013; (5):30-4. PubMed ID: 24437237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generics Substitution, Bioequivalence Standards, and International Oversight: Complex Issues Facing the FDA.
    Bate R; Mathur A; Lever HM; Thakur D; Graedon J; Cooperman T; Mason P; Fox ER
    Trends Pharmacol Sci; 2016 Mar; 37(3):184-191. PubMed ID: 26687297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential concerns about generic substitution: bioequivalence versus therapeutic equivalence of different amlodipine salt forms.
    Meredith PA
    Curr Med Res Opin; 2009 Sep; 25(9):2179-89. PubMed ID: 19601710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.